Your browser doesn't support javascript.
loading
Immune Checkpoint Inhibition as Single Therapy for Synchronous Cancers Exhibiting Hypermutation: An IRRDC Study.
Henderson, Jacob J; Das, Anirban; Morgenstern, Daniel A; Sudhaman, Sumedha; Bianchi, Vanessa; Chung, Jill; Negm, Logine; Edwards, Melissa; Kram, David E; Osborn, Michael; Hawkins, Cynthia; Bouffet, Eric; Cho, Yoon-Jae; Tabori, Uri.
Afiliación
  • Henderson JJ; Mary Bridge Children's Hospital, Division of Pediatric Hematology/Oncology, Tacoma, WA.
  • Das A; Papé Pediatric Research Institute, Division of Pediatric Neurology, Department of Pediatrics, Oregon Health and Sciences University, Portland, OR.
  • Morgenstern DA; Hospital for Sick Children and University of Toronto, Toronto, CA.
  • Sudhaman S; Hospital for Sick Children and University of Toronto, Toronto, CA.
  • Bianchi V; Hospital for Sick Children and University of Toronto, Toronto, CA.
  • Chung J; Hospital for Sick Children and University of Toronto, Toronto, CA.
  • Negm L; Hospital for Sick Children and University of Toronto, Toronto, CA.
  • Edwards M; Hospital for Sick Children and University of Toronto, Toronto, CA.
  • Kram DE; Hospital for Sick Children and University of Toronto, Toronto, CA.
  • Osborn M; Section of Pediatric Hematology-Oncology, Department of Pediatrics, Wake Forest School of Medicine, Winston Salem, NC.
  • Hawkins C; Royal Adelaide Hospital, Adelaide, Australia.
  • Bouffet E; Women's and Children's Hospital, North Adelaide, Australia.
  • Cho YJ; Hospital for Sick Children and University of Toronto, Toronto, CA.
  • Tabori U; Hospital for Sick Children and University of Toronto, Toronto, CA.
JCO Precis Oncol ; 6: e2100286, 2022 03.
Article en En | MEDLINE | ID: mdl-35235414

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inhibidores de Puntos de Control Inmunológico / Neoplasias Idioma: En Revista: JCO Precis Oncol Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inhibidores de Puntos de Control Inmunológico / Neoplasias Idioma: En Revista: JCO Precis Oncol Año: 2022 Tipo del documento: Article